Chemotherapy-induced Thrombocytopenia clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
open to eligible people ages 18-100
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer
Orange, California and other locations
Last updated: